Viatris Income Taxes 2010-2024 | VTRS

Viatris annual/quarterly income taxes history and growth rate from 2010 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
  • Viatris income taxes for the quarter ending September 30, 2024 were $-0.004B, a 106.09% decline year-over-year.
  • Viatris income taxes for the twelve months ending September 30, 2024 were $-0.068B, a 109.84% decline year-over-year.
  • Viatris annual income taxes for 2023 were $0.148B, a 79.83% decline from 2022.
  • Viatris annual income taxes for 2022 were $0.735B, a 21.48% increase from 2021.
  • Viatris annual income taxes for 2021 were $0.605B, a 1278.75% decline from 2020.
Viatris Annual Income Taxes
(Millions of US $)
2023 $148
2022 $735
2021 $605
2020 $-51
2019 $138
2018 $-54
2017 $207
2016 $-358
2015 $68
2014 $41
2013 $121
2012 $161
2011 $116
2010 $10
2009 $-21
Viatris Quarterly Income Taxes
(Millions of US $)
2024-09-30 $-4
2024-06-30 $-65
2024-03-31 $91
2023-12-31 $-89
2023-09-30 $71
2023-06-30 $69
2023-03-31 $98
2022-12-31 $458
2022-09-30 $73
2022-06-30 $75
2022-03-31 $128
2021-12-31 $60
2021-09-30 $-112
2021-06-30 $60
2021-03-31 $596
2020-12-31 $-98
2020-09-30 $56
2020-06-30 $-19
2020-03-31 $10
2019-12-31 $115
2019-09-30 $-4
2019-06-30 $116
2019-03-31 $-90
2018-12-31 $26
2018-09-30 $16
2018-06-30 $-19
2018-03-31 $-77
2017-12-31 $83
2017-09-30 $91
2017-06-30 $28
2017-03-31 $5
2016-12-31 $-193
2016-09-30 $-206
2016-06-30 $35
2016-03-31 $5
2015-12-31 $24
2015-09-30 $27
2015-06-30 $13
2015-03-31 $5
2014-12-31 $82
2014-09-30 $-87
2014-06-30 $11
2014-03-31 $35
2013-12-31 $12
2013-09-30 $36
2013-06-30 $41
2013-03-31 $32
2012-12-31 $29
2012-09-30 $53
2012-06-30 $51
2012-03-31 $29
2011-12-31 $-1
2011-09-30 $35
2011-06-30 $56
2011-03-31 $26
2010-12-31 $-23
2010-09-30 $-12
2010-06-30 $14
2010-03-31 $31
2009-12-31 $-73
2009-09-30 $-11
2009-06-30 $26
2009-03-31 $37
Sector Industry Market Cap Revenue
Medical Medical Services $15.576B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00